Prosight Management as of March 31, 2025
Portfolio Holdings for Prosight Management
Prosight Management holds 38 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 10.9 | $33M | 1.3M | 25.12 | |
| Meiragtx Holdings (MGTX) | 8.2 | $25M | 3.7M | 6.78 | |
| Bridgebio Pharma (BBIO) | 6.9 | $21M | 610k | 34.57 | |
| Janux Therapeutics (JANX) | 6.1 | $19M | 690k | 27.00 | |
| Roivant Sciences SHS (ROIV) | 6.1 | $18M | 1.8M | 10.09 | |
| Mirum Pharmaceuticals (MIRM) | 5.1 | $16M | 343k | 45.05 | |
| Kura Oncology (KURA) | 4.5 | $14M | 2.1M | 6.60 | |
| Adc Therapeutics Sa SHS (ADCT) | 4.4 | $14M | 9.5M | 1.41 | |
| Zymeworks Del (ZYME) | 3.7 | $11M | 957k | 11.91 | |
| Amicus Therapeutics (FOLD) | 3.7 | $11M | 1.4M | 8.16 | |
| Icon SHS (ICLR) | 3.5 | $11M | 60k | 174.99 | |
| Rocket Pharmaceuticals (RCKT) | 3.2 | $9.9M | 1.5M | 6.67 | |
| Acadia Healthcare (ACHC) | 2.9 | $8.8M | 290k | 30.32 | |
| Argenx Se Sponsored Adr (ARGX) | 2.7 | $8.1M | 14k | 591.87 | |
| Schrodinger (SDGR) | 2.5 | $7.6M | 385k | 19.74 | |
| Syndax Pharmaceuticals (SNDX) | 2.5 | $7.5M | 609k | 12.29 | |
| Tectonic Therapeutic (TECX) | 2.3 | $7.1M | 399k | 17.71 | |
| Intuitive Surgical Com New (ISRG) | 2.3 | $6.9M | 14k | 495.27 | |
| Shattuck Labs (STTK) | 2.1 | $6.3M | 6.6M | 0.95 | |
| Abcellera Biologics (ABCL) | 2.1 | $6.3M | 2.8M | 2.23 | |
| Immunovant (IMVT) | 2.0 | $6.2M | 360k | 17.09 | |
| Prothena Corp SHS (PRTA) | 1.7 | $5.1M | 408k | 12.38 | |
| Livanova SHS (LIVN) | 1.6 | $5.0M | 127k | 39.28 | |
| Haemonetics Corporation (HAE) | 1.4 | $4.2M | 65k | 63.55 | |
| Blueprint Medicines (BPMC) | 1.1 | $3.2M | 37k | 88.51 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.0 | $3.1M | 575k | 5.31 | |
| Cytomx Therapeutics (CTMX) | 0.8 | $2.5M | 3.9M | 0.64 | |
| Caredx (CDNA) | 0.8 | $2.4M | 137k | 17.75 | |
| Biohaven (BHVN) | 0.8 | $2.4M | 100k | 24.04 | |
| Addus Homecare Corp (ADUS) | 0.8 | $2.4M | 24k | 98.89 | |
| Sight Sciences (SGHT) | 0.8 | $2.3M | 969k | 2.40 | |
| Erasca (ERAS) | 0.4 | $1.3M | 947k | 1.37 | |
| Spyre Therapeutics Com New (SYRE) | 0.4 | $1.2M | 75k | 16.14 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.3 | $802k | 187k | 4.30 | |
| Rein Therapeutics Com New (RNTX) | 0.3 | $761k | 430k | 1.77 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.2 | $533k | 423k | 1.26 | |
| Pliant Therapeutics (PLRX) | 0.1 | $451k | 334k | 1.35 | |
| Immunome (IMNM) | 0.1 | $159k | 24k | 6.73 |
